Biotech & Pharma Updates | March 15 - 16, 2026
🧬 Roche + Nvidia expand AI partnership with 2,176 Blackwell GPUs for drug and diagnostic development, Federal judge blocks RFK Jr.'s childhood vaccine schedule changes + halts CDC advisory panel appointments, Unnatural Products raises $45M Series B, macrocyclic peptides for undruggable targets, CytomX Therapeutics reports positive Ph1 data for Varseta-M antibody-drug conjugate in colorectal cancer, Eli Lilly's Ebglyss IL-13 inhibitor hits Ph3 endpoints in pediatric atopic dermatitis - setting up label expansion, AstraZeneca's Imfinzi (durvalumab) wins EU approval for resectable gastric and gastroesophageal junction cancers following Ph3 success
